Kiropraktor Jens-Jørn Dahl ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  8.7% 7.3% 7.0% 6.4% 4.2%  
Credit score (0-100)  30 33 33 36 47  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  207 11.0 44.8 56.5 247  
EBITDA  207 11.0 28.8 44.5 171  
EBIT  207 11.0 28.8 42.0 151  
Pre-tax profit (PTP)  207.1 10.5 27.6 41.2 150.5  
Net earnings  160.2 7.0 21.0 31.0 114.6  
Pre-tax profit without non-rec. items  207 10.5 27.6 41.2 150  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 36.0 36.0 83.5 364  
Shareholders equity total  137 144 165 196 311  
Interest-bearing liabilities  89.2 109 92.2 47.2 3.7  
Balance sheet total (assets)  278 308 318 326 470  

Net Debt  69.4 8.7 -11.4 45.5 -102  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  207 11.0 44.8 56.5 247  
Gross profit growth  0.0% -94.7% 308.0% 26.2% 337.3%  
Employees  0 0 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  278 308 318 326 470  
Balance sheet change%  76.1% 10.7% 3.3% 2.4% 44.1%  
Added value  207.2 11.0 28.8 42.0 171.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 36 0 45 260  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 64.3% 74.3% 61.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  90.2% 3.7% 9.2% 13.1% 38.0%  
ROI %  98.9% 4.3% 10.7% 15.6% 49.9%  
ROE %  108.7% 5.0% 13.6% 17.2% 45.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  49.2% 46.7% 51.9% 60.1% 66.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  33.5% 79.0% -39.7% 102.2% -59.8%  
Gearing %  65.1% 75.7% 55.9% 24.1% 1.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.4% 1.1% 1.2% 2.4%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.1 0.8 0.9 0.9 0.8  
Current Ratio  1.1 0.8 0.9 0.9 0.8  
Cash and cash equivalent  19.8 100.2 103.6 1.7 106.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  8.4 -29.8 -7.6 -13.9 -28.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 29 42 171  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 29 45 171  
EBIT / employee  0 0 29 42 151  
Net earnings / employee  0 0 21 31 115